What Is EMA Drug Approval?
EMA drug approval is a type of regulatory process to evaluate medicines for the purpose of its use in markets of Europe. The European Medicines Agency (EMA) would assess all scientific evidence related to the quality, efficacy, and safety of the drug so that it can be authorized in one of the European regulatory paths.
What Is FDA Drug Approval?
FDA drug approval refers to the procedure in which the FDA assesses a novel medicine to ascertain whether it is effective and safe for the targeted objective. This procedure requires thorough research, trials, and the assessment of the approaches used by the relevant authorities before a drug can be offered for sale in the US.
What is Aggregate Safety Reports?
Aggregate Safety Reports are crucial documents in pharmacovigilance that give a thorough examination of the safety profile of a medicinal product within a specific reporting period.
FDA 510(k) Submission: A Complete Guide for Regulatory Professionals
What is an FDA 510(k) Submission?
An FDA 510(k) submission is a pre-market notification that is submitted to the U.S. Food and Drug Administration (FDA) to show that a new medical device is substantially equivalent to a legally marketed predicate medical device.
What is a Master Validation Plan (MVP)?
In the pharmaceutical industry, maintaining product quality, regulatory compliance, and patient safety is non-negotiable. A Master Validation Plan (MVP) serves as the foundation for organizing and controlling all validation activities within a manufacturing facility.